Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis

BACKGROUND: We performed a systematic review and meta-analysis to evaluate the risks of cardiac adverse events in solid tumor patients treated with monotherapy of immune checkpoint inhibitors (ICIs) or combined therapy of ICIs plus chemotherapy. METHODS: Eligible studies were selected through the fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jiexuan, Tian, Ruyue, Ma, Yingjie, Zhen, Hongchao, Ma, Xiao, Su, Qiang, Cao, Bangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190385/
https://www.ncbi.nlm.nih.gov/pubmed/34123795
http://dx.doi.org/10.3389/fonc.2021.645245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190385/
https://www.ncbi.nlm.nih.gov/pubmed/34123795
http://dx.doi.org/10.3389/fonc.2021.645245

Ejemplares similares